I don't own stock in HMPR but do plan to keep this bank

New Post Public Reply Private Reply Replies (1) Message Board
SaltyMutt

I don't own stock in HMPR but do plan to keep this bank on my radar. Based in Virginia, this bank has assets of over 1.7 billion dollars which makes it a bit bigger than the banks I usually follow. Over the last year The Bank of Hampton Roads has made some good strides in returning to profitability. One massive thing in their favor is that not one cent of TARP money was ever taken. The pps is at 1.31 as of this post but don't expect it to remain there. I think HMPR will be a solid 2.00 + stock by the end of 2013.

VectorVest Logo
Hampton Roads (HMPR)
$1.31
0.02 (1.55%)
Thursday, March 28, 2013
HMPR is fairly valued compared to its Price of $1.31 per share , has below average safety , and is currently rated a Hold.

Hampton Roads (HMPR)


Bank (Southeast)


Company Information

Business: Hampton Roads Bankshares, Inc., incorporated on February 28, 2001, primarily serves as a holding company for the Bank of Hampton Roads (BOHR). The Company engages in a general community and commercial banking business, emphasizing the needs of individuals, and small to medium-sized businesses in its primary service areas, which include South Hampton Roads, Virginia, the Northeastern, Southeastern and Research Triangle regions of North Carolina, the Eastern Shore of Virginia and Maryland, and Richmond, Virginia.

Capital Appreciation

Value: Value is a measure of a stock's current worth. HMPR has a current Value of $1.37 per share. Therefore, it is fairly valued compared to its Price of $1.31 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. VectorVest advocates the purchase of undervalued stocks. At some point in time, a stock's Price and Value always will converge.

RV (Relative Value): RV is an indicator of long-term price appreciation potential. HMPR has an RV of 0.78, which is poor on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. VectorVest favors the purchase of stocks with RV ratings above 1.00.



RS (Relative Safety): RS is an indicator of risk. HMPR has an RS rating of 0.54, which is poor on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock in the VectorVest database. VectorVest favors the purchase of stocks of companies with consistent, predictable financial performance.

RT (Relative Timing): RT is a fast, smart, accurate indicator of a stock's price trend. HMPR has a Relative Timing rating of 1.02, which is fair on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock's price movements over one day, one week, one quarter and one year time periods. Once a stock's price has established a strong trend, it is expected to continue in that trend for the short-term. If a trend dissipates, RT will gravitate toward 1.00. RT will explode from bottoms, dive from tops, and reflect changes in price momentum. VectorVest favors the purchase of stocks with RT ratings above 1.00.

VST (VST-Vector): VST is the master indicator for ranking every stock in the VectorVest database. HMPR has a VST rating of 0.82, which is poor on a scale of 0.00 to 2.00. VST is computed from the square root of a weighted sum of the squares of RV, RS, and RT. Stocks with the highest VST ratings have the best combinations of Value, Safety and Timing. These are the stocks to own for above average, long-term capital appreciation. VectorVest advocates the purchase of safe, undervalued stocks rising in price.

Recommendation (REC): VectorVest gives a Buy, Sell, Hold recommendation on every stock, every day. HMPR has a Hold recommendation. REC reflects the cumulative effect of all the VectorVest parameters working together. These parameters are designed to help investors buy safe, undervalued stocks rising in price. They also help investors avoid or sell risky, overvalued stocks falling in price. VectorVest recommends that investors buy high VST-Vector, Buy-rated stocks in rising markets.

Stop (Stop-Price): Stop is an indicator of when to sell a long position or cover a short position. HMPR has a Stop of $1.24 per share. This is $0.07 below below HMPR's current closing Price. A stock's Stop is computed from a 13 week moving average of its closing prices, and is fine-tuned according to the stock's fundamentals. High RV, high RS stocks have lower Stops, and low RV, low RS stocks have higher Stops. In the VectorVest system, a stock gets a 'B' or 'H' recommendation if its Price is above its Stop and an 'S' recommendation if its Price is below its Stop.

GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. HMPR has a forecasted Earnings Growth Rate of -7.00%, which VectorVest considers to be very poor. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the VectorVest database. GRT often foretells a stock's future price trend. If a stock's GRT trend is upward, the stock's price will likely rise. If GRT is trending downward, the stock's Price will probably fall. VectorVest favors the purchase of stocks whose GRT is rising and is greater than the sum of current inflation and interest rates, as shown weekly in our investment climate report.

EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. HMPR has a forecasted EPS of $-1.29 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.

P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. HMPR has a P/E of -1.02. This ratio may be deemed to be high or low depending upon your frame of reference. The average P/E of all the stocks in the VectorVest database is 40.25. P/E is computed daily using the formula: P/E = Price/EPS.

EY (Earnings Yield): EY reflects earnings per share as a percent of Price. EY is related to P/E via the formula, EY = 100 / (P/E), and may be used in place of P/E as a measure of valuation. EY has the advantages that it is always determinate and can reflect negative earnings. HMPR has an EY of -98.47 percent. This is below the current average of 2.50% for all the stocks in the VectorVest database. EY equals 100 x (EPS/Price).

GPE (Growth to P/E Ratio): GPE is another popular measure of stock valuation. It compares earnings growth rate to P/E ratio. HMPR has a GPE rating of -6.90. High growth stocks are believed to be able to justify high P/E ratios. A stock is commonly considered to be undervalued when GPE is greater than 1.00 and overvalued when GPE is below 1.00. Unfortunately, this rule of thumb does not take into account the effect of interest rates on P/E ratios. The operative GPE ratio of 1.00 is valid when and only when interest rates equal 10%. With long-term interest rates currently at 2.57%, the operative GPE ratio is 0.07. Therefore, HMPR may be considered to be fairly valued.

Dividend Information

DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. HMPR does not pay a dividend.

DY (Dividend Yield): DY reflects dividend per share as a percent of Price. HMPR does not pay a dividend, so it does not have a Dividend Yield rating . DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.

DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. HMPR does not pay a dividend, so it does not have a Dividend Safety rating . Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.

DG (Dividend Growth Rate): Dividend Growth is a subtle yet important indicator of a company's financial performance. It also provides some insight into the board's outlook on the company's ability to increase earnings. HMPR does not pay a dividend, so it does not have a Dividend Growth rating .

YSG (YSG-Vector): YSG is an indicator which combines DIV, DY and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. HMPR does not pay a dividend, so it does not have a YSG rating which is . Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for below current income and long-term growth.

Price-Volume Data

Price: HMPR closed on Thursday, March 28, 2013 at $1.31 per share.

Open: HMPR opened trading at a price of $1.32 per share on Thursday, March 28, 2013.

High: HMPR traded at a High price of $1.34 per share on Thursday, March 28, 2013.

Low: HMPR traded at a Low price of $1.31 per share on Thursday, March 28, 2013.

Close: HMPR closed on Thursday, March 28, 2013 at $1.31 per share. (Close is also called Price in the VectorVest system)

Range: Range reflects the difference between the High and Low prices for the day. HMPR traded with a range of $0.03 per share on Thursday, March 28, 2013.

$ Change: HMPR up 0.02 from the prior day's closing Price.

%PRC: HMPR's Price changed 1.55% from the prior day's closing price.

Volume: HMPR traded 82,684 shares on Thursday, March 28, 2013.

AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. HMPR has an AvgVol of 144,732 shares traded per day.

%Vol: %Vol reflects the percent change in today's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. HMPR had a %Vol of -42.87% on Thursday, March 28, 2013

CI (Comfort Index): CI is an indicator which reflects a stock's ability to resist severe and/or lengthy price declines. HMPR has a CI rating of 0.40, which is very poor on a scale of 0.00 to 2.00. CI is quite different from RS in that it is based solely upon a stock's long-term price history. VectorVest advocates the purchase of high CI stocks.

Sales / Market Capitalization Information

Sales: HMPR has annual sales of 82,000,000

Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. HMPR has a Sales Growth of -12.00% per year. This is very poor. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company's operations.

Sales Per Share (SPS): HMPR has annual sales of $0.48 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.

Price to Sales Ratio (P/S): HMPR has a P/S of 2.71. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.

Shares: HMPR has 170,000,000 shares of stock outstanding.

Market Capitalization: HMPR has a Market Capitalization of 223,000,000. Market Capitalization is calculated by multiplying price times shares outstanding.

Business Sector: HMPR has been assigned to the Bank Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

Industry Group: HMPR has been assigned to the Bank (Southeast) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

For another stock analysis, please click here.

Please do not reply to this email. For answers to your questions, please call 1-888-658-7638, or email us at support@vectorvest.com .

Copyright 2010 by VectorVest, Inc. All Rights Reserved.
20472 Chartwell Center Drive, Cornelius NC 28031
For additional information, call 1-888-658-7638, e-mail to support@vectorvest.com ,
or visit our internet site at http://www.vectorvest.com

For international phone numbers please click here.

DISCLAIMER: VectorVest is licensed by VectorVest, Inc., and is protected by United States copyright laws and international treaty provisions. The information contained herein is for your exclusive, personal use only. You may print a single copy of any stock analysis for your exclusive use, but it is not to be reproduced for distribution without the expressed written consent of VectorVest, Inc. You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. This material is believed to be reliable, but neither VectorVest, Inc., nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by VectorVest, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.

VectorVest is comprised of reports embodying a unique system of stock analysis. All contents and recommendations are based on data and sources believed to be reliable, but accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied. VectorVest and/or its principals may purchase or sell any of the securities cited herein. VectorVest and the logostyle, geometric design are, individually and collectively, service marks owned by VectorVest, Inc. VectorVest is published daily by VectorVest, Inc. 20472 Chartwell Center Drive Cornelius, NC 28031 704-895-4095



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 0

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
U.S. Gold Corp. Gears Up for Key October Event

Updated Category News Views 37

Marking Calendars for the Emerging Growth Showdown There's nothing quite like the buzz leading up to an event where you know someone’s either gonna make a splash or barely leave a ripple. U.S. Gold Corp. is drawing some attention ahead of the Emerging Growth Conference on October 29, 2026. This ain't just any corporate dog-and-pony show—it's a chance for the Gold...

Continue Reading
Ellucian's Cloud Hat-Trick: Leading AI in Education

Updated Category News Views 66

Turning the Dial on Cloud Innovation What’s gripping the talk of the town? It's the powerhouse, Ellucian, clinching the 2026 Stratus Award for Cloud Computing in the Education category, marking a third straight victory. It’s a trifecta that signals something big in the world of higher ed tech. But what does it mean for investors and the sector at large? Unpacking the...

Continue Reading
Medefy's New Award Honors Cost-Savvy Consultants

Updated Category News Views 59

Awarding Ingenuity in Healthcare Cost Containment Ditch the chatter, folks. Let’s talk about a little piece of news that just might be the ripple effect the healthcare sector needs right now. Medefy, that cost-containment whiz, has unleashed 'The Curve Bender Award.' Frankly, it's about time someone spotlighted the gritty work of benefits consultants grinding in the...

Continue Reading
Nektar Therapeutics Gears Up for Q3 Financial Reveal

Updated Category News Views 34

Anticipation Builds as Nektar Preps Financial Report Ah, the life of a biotech investor, riding high or gripping the rail as tides turn with every quarterly report. This time, we're turning our gaze to Nektar Therapeutics and their Q3 financial results slated for release on November 12th, just as the market dust starts settling for the day. Now, if you’re wired to...

Continue Reading
Innodata Faces Investigation After Major Stock Drop

Updated Category News Views 26

Rough Waters for Innodata, Stock Takes a Hit The market can be a brutal place when news hits hard, and that's precisely the situation Innodata Inc. (NASDAQ: INOD) found itself in on October 27, 2026. After a promising rally, the company's shares plummeted by over 20% when news broke of a significant workforce reduction overseas. Unpacking the Numbers Behind the Dive The...

Continue Reading
Fashion Sees Quality Trumping Price in Consumer Preferences

Updated Category News Views 22

Consumers Are Shifting Away from Price-First Mindset You could always count on shoppers looking for a bargain, right? Well, hold your horses, 'cause that train's rolling off the tracks. In today's fashion shuffle, good ol' quality and craftsmanship are giving low prices a run for their money. A study spearheaded by Boston Consulting Group (BCG) and Women's Wear Daily...

Continue Reading
Ferrovial's EUR 600M Scrip Dividend: What's Brewing?

Updated Category News Views 68

Understanding Ferrovial's Latest Financial Maneuver Alright, investors, listen up—Ferrovial's just tossed a hefty EUR 600 million scrip dividend onto the table, giving shareholders the choice between cash or shares. Now, if you've been around the block, this sort of move can mean a few things, and it's best not to treat it like coins rattling in a collection plate. This...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 51

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Covalent's Bet on AML Analytics: A Defense Revolution

Updated Category News Views 11

The Big Play: AI Meets Financial Defense You know when a private equity firm swoops in, it's like the cavalry arriving. Covalent Equity Partners just did that for AML Analytics, or AMLA for short. A payday for them, sure, but it's more about amplifying AMLA's already hefty punch against financial crime, using AI to boot. Now, if AI's mentioned, you know someone's getting...

Continue Reading

Top 5 Most Recently Viewed Articles

Defense Metals Welcomes Ali Mahdavi as New SVP for Growth

Updated Category News Views 262

Defense Metals Welcomes Ali Mahdavi as New SVP for Growth Defense Metals Corp. (TSXV: DEFN) is thrilled to announce that Ali Mahdavi has joined as Senior Vice President of Corporate Development. This strategic appointment aims to bolster the Company's leadership team as they work diligently on their Wicheeda Project. Strengthening Leadership for Strategic Growth Mark...

Continue Reading
Insightful Economic Trends Expected by Chapman University 2026

Updated Category News Views 150

Understanding the Chapman University Economic Forecast for 2026 Chapman University has disclosed key insights from its much-anticipated economic forecast for 2026, a resource utilized for nearly five decades by business leaders and policymakers. The report highlights expectations for real GDP growth of approximately 2.0% in 2026, a noticeable increase from the predicted...

Continue Reading
Pyxis Oncology Welcomes New Vice President for Investor Relations

Updated Category News Views 192

Introduction to Alex Kane's Appointment Pyxis Oncology, Inc. (NASDAQ: PYXS), a pioneering clinical-stage firm dedicated to developing antibody-drug conjugates for challenging cancers, has taken a significant step by appointing Alex Kane as their Senior Vice President of Investor Relations and Capital Markets, effective immediately. Alex Kane's Impressive Background...

Continue Reading
CEO Terry Mendez's Vision for Safe Harbor Financial Success

Updated Category News Views 508

Terry Mendez’s Vision for Safe Harbor Financial's Future GOLDEN, Colo. — SHF Holdings, Inc., operating as Safe Harbor Financial (Nasdaq: SHFS), is reaching a pivotal moment in its journey. In a recent announcement, the newly appointed CEO, Terry Mendez, addressed shareholders, sharing his aspirations and strategic focus for the company. As a key player in providing...

Continue Reading
Gentuity's HF-OCT Imaging System Gains FDA Clearance

Updated Category News Views 75

Gentuity's HF-OCT Imaging System Gains FDA Clearance Gentuity, LLC, a leader in innovative intravascular imaging technologies, has recently celebrated a significant triumph with the FDA's approval of its HF-OCT Imaging System. This cutting-edge device is designed for both pre- and post-percutaneous coronary intervention (PCI) imaging, marking it as a groundbreaking tool...

Continue Reading